To date there has been no systematic review on the use of epidural steroids in patients undergoing lumbar spine surgery for degenerative spinal disease; there have, however, been several randomized studies without conclusive results. 3, 6, 15, 27, 31, 34, 35, 43 This systematic review addresses the following clinical question: In adults undergoing lumbar spine surgery for degenerative spinal disease, do epidural steroids compared with standard therapy reduce pain, improve QOL, improve the ability to return to work, decrease LOS, or increase the risk of adverse events?
Methods

Search Methods
The databases Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase were searched for relevant articles without language restrictions. Medtronic and Cervitech were contacted regarding any unpublished studies. Websites of the United States Food and Drug Administration (http://www.fda.gov/), the Spinal Society of Australia (http://www.spinesociety.org. au/), the California Spine Institute for Minimally Invasive Spinal Surgery (http://www.spinecenter.com/), the International Spinal Cord Society (http://www.iscos.org. uk/), and the Congress of Neurological Surgeons (http:// www.neurosurgeon.org/) were searched for abstracts of unpublished studies. The date of the last search for this review was December 14, 2009 . Search terms included "laminectomy," "discectomy," "steroid," "methylprednisolone," "dexamethasone," "hydrocortisone," "spinal anesthesia," and "randomized controlled trials." Advanced search methods were used with the MeSH terms and text-word functions.
Inclusion and Exclusion Criteria
Criteria for inclusion were randomized or quasirandomized controlled trials as defined by the Cochrane Collaboration. 20 Studies of patients over the age of 18 years undergoing lumbar spine surgery for degenerative spinal disease with spinal stenosis or nerve root compression were included. Since we aimed to summarize all available evidence in our review, strict diagnostic criteria were not applied as inclusion criteria to avoid excluding important trial evidence. Trials needed to assess steroids administered to the epidural space between 1 week before and after the operation. The route, frequency, and type of steroid were not restricted. Trials that compared epidural steroids to an active or inactive control without steroids were included.
Primary Outcomes
Postoperative back and radicular pain were assessed separately. Continuous and ordinal patient-measured pain scores were included in the meta-analyses. When the type of pain was not specified, meta-analysis was performed including scores for both back and radicular pain and then these scores were removed for sensitivity analyses. Quality of life scores reported as continuous or ordinal patient-measured scores were included in the analysis. Where trials reported outcomes at several time points postoperatively, data were summarized and meta-analysis was performed using the time points most common across all trials.
Secondary Outcomes
Total consumption of postoperative analgesic medication was assessed as a surrogate measure of pain. With respect to the risk of not returning to full time, metaanalysis was performed using measurements from similar postoperative time points. Postoperative LOS was also assessed.
Adverse Events
With respect to adverse events, meta-analysis was performed using the measurements closest to 3 months of follow-up.
Two authors (S.C.R. and D.L.) extracted the information using a structured template. Information on the type, dose, and method of application of steroid or comparator drug was recorded. The use of analgesic agents in conjunction with the epidural steroids, or cointervention analgesia, was documented. Mean age, sex, surgical procedure, and the indication for surgery, sample size, study location, follow-up duration, and outcome score tools were noted. Methodological quality was assessed using the Cochrane Collaboration's criteria for assessing risk of bias. 20 When the authors did not agree, consensus was reached through discussion. Differences in the method of steroid application, the use of cointervention analgesia, and the outcome score tools were considered as potential sources of clinical heterogeneity.
Statistical Methods
Continuous and dichotomous outcomes were pooled using random effects modeling, with the effect measures presented as standardized mean differences (SMD) or relative risks (RR). These methods accounted for variability of the primary outcome measurement scales. Statistical heterogeneity was assessed using the I 2 statistic. Review Manager 5 version 5.0.20 was used to perform the statistical analyses.
Where data were presented heterogeneously across trials, equations recommended by the Cochrane Collaboration were used to calculate and impute data. This was done to convert standard error to standard deviation, or to estimate variability where a trial had not reported either a standard error or deviation. 20 In trials with multiple control groups, formulae recommended by the Cochrane Collaboration were used to combine the groups. Ordinal scores were converted into numerical values and pooled with the continuous scores. For outcomes when median and not mean was provided, a decision was made to impute the mean and standard deviations from the median and range using published statistical conversions. 21 To examine potential sources of heterogeneity, subgroup analyses were performed on trials with cointervention analgesia as it was hypothesized that the treatment effect would be greater in these groups. Studies that were not included in the meta-analyses because they did not report any useable data for the review outcomes were assessed separately.
Results
The database search identified 114 potentially eligible trials in CENTRAL, 864 in MEDLINE, and 1253 in Embase (Fig. 1) . Review of reference lists of included studies found a further 5 potentially eligible trials. Review of online abstracts or journals did not identify any additional trials. In total, 2236 references were screened for inclusion in the review.
Thirty-one citations to potentially eligible trials were identified and reviewed in full text for inclusion. Nineteen studies were excluded: in 7 trials steroids were not administered into the epidural space; 9, 16, 18, 25, 33, 47, 49 in 2 studies they were not administered during the perioperative period; 44, 45 in 1 study no relevant outcomes were reported; 12 7 studies were not randomized or quasi-randomized controlled trials; [3] [4] [5] 10, 11, 19, 24 and 2 articles were reports on trials already included for analysis. 31, 46 Twelve trials were selected for inclusion in the review, including a total of 1053 participants. A summary of the trial characteristics is presented in Table 1 . All trials reported on epidural steroids in adults undergoing surgery for herniated lumbar discs. Laminotomies or decompressive laminectomies with discectomies were performed in all the trials. Spinal fusions were performed in 1 trial only. 23 In 5 trials epidural methylprednisolone was administered at a dosage of 80 mg; 6, 15, 22, 23, 31 in 5, epidural methylprednisolone was administered at a dosage of 40 mg; 27, 29, 34, 35, 43 in 1 trial epidural dexamethasone was administered at 8 mg; 7 and in 1, epidural dexamethasone was administered at 4 mg. 1 In 6 trials cointervention analgesia was used, 15, 22, 23, 31, 34, 35 with bupivacaine, morphine, or steroids administered intravenously. Three trials compared epidural steroids to both an inactive and active control 15, 29, 34 and 1 trial 34 included 2 groups receiving epidural steroids. The mean patient age ranged from 38 to 52 years and the proportion of male subjects ranged from 40% to 87%.
The methodological quality of the trials is summarized in Table 2 using the criteria suggested by the Cochrane Collaboration. 20 Lack of allocation concealment and investigator blinding were noted in the majority of the studies. A source of outcome reporting bias was that half the studies reported outcomes incompletely and thus could not be entered into all the meta-analyses. 1, 6, 15, 23, 29, 31 Validated patient-measured outcomes were not used in all the studies. Table 3 summarizes the outcome measures reported in the trials.
Pain
The meta-analysis of back pain was based on data from 7 trials (Table 4 and Fig. 2) . 1, 7, 15, 22, 29, 35, 43 There was a trend toward benefit with epidural steroids at all time points. The SMD was statistically significant at 12-24 hours postoperatively (SMD -1.26, 95% CI -2.35 to -0.0.18, p = 0.02), but not at Day 2, 1 week, or 1-2 months postoperatively.
A subgroup analysis of trials with and without cointervention analgesia showed a trend toward benefit in both groups (SMD -1.73, 95% CI -4.20 to 0.74, p = 0.17 and SMD -0.82, 95% CI -1.87 to 0.23, p = 0.13, respectively). The results of sensitivity analysis without Ang et al. 1988, 1 a study in which ordinal scores were transformed into continuous scores, were not statistically significant. Statistical significance was maintained in the sensitivity analyses without the studies by Hurlbert et al., 22 Dikmen et al., 7 in which any pain-not specifically back pain-was reported, or without the study by Glasser et al., 15 in which ordinal scores were transformed into continuous scores.
The meta-analysis of radicular pain was based on data from 5 trials (Fig. 3 and Table 4) . 7, 15, 22, 29, 43 There was a benefit with epidural steroids at 1 week postoperatively (SMD -0.71, 95% CI -1.19 to -0.24, p = 0.003) and 1-2 months postoperatively (SMD -2.14, 95% CI -3.47 to -0.81, p = 0.002), but not at 1 day or 2 days postoperatively. The results of sensitivity analyses performed without the study of Hurlbert et al., 1999, 22 in which any pain and not radicular pain was reported, were not statistically significant.
Except in the analysis of radicular pain at 1 week postoperatively, the value for I 2 ranged from 50% to 97%, indicating considerable heterogeneity among studies. Differences in the use of epidural steroids and the characteristics of the patient-measured pain scales were likely to be contributors to heterogeneity.
The following 4 studies were not included in the metaanalyses because they lacked usable data. Debi et al. 6 reported that epidural steroids decreased back pain but not radicular pain in the first 2 weeks postoperatively. Jirarattanaphochai et al. 23 reported that epidural steroids reduced back pain in the first 48 hours and radicular pain in the 1st week postoperatively. Lundin et al. 31 reported that epidural steroids lowered pain throughout the first 2 years postoperatively but that this was not statistically significant. Rasmussen et al. 43 reported that epidural steroids decreased radicular pain throughout the 2 years of follow-up.
Quality of Life
Five studies were included in the meta-analysis of QOL scores (Fig. 4 and Table 4) . 15, 22, 23, 27, 31 Scales used by the trials included the SF-36, the Disability Rating Index, an 8-point outcome scale, and a 5-point functional grade scale created by study authors. At 1 month to 6 weeks postoperatively, there was a trend toward benefit with epidural steroids but it was not statistically significant. At 12 weeks to 3 months postoperatively there was no difference in QOL scores. The results of tests for heterogeneity were not significant for either meta-analysis (I 2 = 0%). 20 : sequence generation, allocation concealment, blinding, outcome data, selective outcome reporting, and baseline characteristics. Abbreviations: Adeq = Adequate; Alloc = Allocation; Compl = complete; Concealmt = Concealment; Gen = generation; Imbal = Imbalance; Q-RCT = quasi-randomized controlled trial; RCT = randomized controlled trial; Sel = selective; Seq = sequence. † All trials were analyzed using the intention-to-treat principle. 
Postoperative Consumption of Analgesic Agents
Seven studies were included in the meta-analysis of data regarding the postoperative consumption of analgesic medication (Fig. 5 and Table 4) . 7, 15, 22, 23, 27, 34, 35 The results showed significantly less analgesic medication consumed in the groups of patients treated with epidural steroids (SMD -0.38, 95% CI -0.62 to -0.14, p = 0.002). There was moderate heterogeneity (I 2 = 39%). The heterogeneity may have been due to differences in methods of measurement, types of analgesic agents, and the size of effects among studies. The subgroup analyses of the trials with and without cointervention analgesia showed similar results, (SMD -0.42, 95% CI -0.78 to -0.06, p = 0.02 and SMD -0.34, 95% CI -0.66 to -0.01, p = 0.04, respectively). The heterogeneity was low in the trials without cointervention analgesia (I 2 = 20%) but remained moderately high in the trials with cointervention analgesia (I 2 = 55%). Differences in the type of adjunctive analgesics could have accounted for heterogeneity in these trials. The study of Ang et al., 1988 1 was not included because the data were not usable for the meta-analysis.
Length of Postoperative Hospital Stay
The meta-analysis of LOS included 4 trials (Fig. 6 and Table 4) . 15, 27, 31, 43 There was a significant decrease in postoperative LOS in the groups treated with epidural steroids (SMD -0.95, 95% CI -1.62 to -0.27, p = 0.006). Cultural differences influencing LOS may have contributed to the considerable heterogeneity (I 2 = 88%).
Return to Full-Time Work
Two trials were included in the meta-analysis of the risk of not returning to full-time work (Fig. 7 and Table  4) . 31, 43 There was a trend toward benefit with epidural ste- roids at all time points. This was statistically significant at 1 year (RR 0.27, 95% CI 0.13-0.57, p = 0.0006) and 2 years (RR 0.26, 95% CI 0.11-0.61, p = 0.002) postoperatively, but not at 12 weeks postoperatively. There was no significant heterogeneity (I 2 = 0%). The 1992 study by Lavyne and Bilsky 27 could not be used in the meta-analysis; however, it reported no difference in the risk of not returning to full-time work.
Adverse Events
Adverse events occurred in 3 of the 11 trials that reported complications (Fig. 8 and Table 4) . 22, 31, 43 There was no significant between-groups difference in the risk of adverse events (RR 1.05, 95% CI 0.22-5.05, p = 0.96). Complications encountered in the steroids group were superficial skin infections in 2 patients 22 and reoperation within 3 months of follow-up in 1 patient. 22 The other 8 studies, involving a total of 554 patients, reported no complications due to epidural steroids. 1, 6, 7, 15, 23, 27, 34, 35 There was no significant heterogeneity (I 2 = 0%).
Publication Bias
Funnel plots were created to assess publication bias (Fig. 9) . The presence of publication bias is suggested by the lack of trials represented in the lower right hand corner and small trials with strongly positive results in the lower left hand corner.
Discussion
Our systematic review found evidence that epidural steroids decrease pain in the 1st week and 1-2 months following lumbar spine surgery for degenerative spinal disease. Epidural steroids reduced the consumption of postoperative analgesics, decreased LOS, and reduced the risk of not returning to full-time work at 1 year after surgery. Data from individual randomized controlled trials demonstrated significant pain reduction up to 2 years postoperatively, 31, 43 although this could not be substantiated in the meta-analysis. There was no statistically significant difference in reported QOL scores or the incidence of adverse events with epidural steroids.
The beneficial effect of epidural steroids on pain and in reducing total postoperative analgesic medication use without increasing the risk of complications makes it an attractive adjunct to regular analgesia. Although statistically significant differences were found, the clinical significance of the benefits may be small. We found pain reduction was reduced overall by approximately 2-3 points on a 10-point scale. 35 Similarly, the total difference in opiate use was an overall reduction of 4 mg for those also treated with epidural steroids. 27 The mean difference in LOS was approximately 1 day. 31 These differences may or may not be judged to be clinically important by clinicians and patients.
The benefit of epidural steroids with respect to the risk of not returning to work by 1 year was surprisingly high. With an absolute risk reduction of 0.157, treating 7 people with epidural steroids (the number needed to treat) would result in 1 person avoiding being unable to return to work by 1 year postsurgery. Although this is the first systematic review on the topic, a small review with similar findings was discussed by Rasmussen et al. 43 The present study is the first review to report that epidural steroids significantly decrease the total postoperative consumption of analgesic agents following lumbar spinal surgery for degenerative spine disease. Despite a case series linking epidural steroids to an increased incidence of adverse events such as wound infection, 30 in our systematic review we found no difference in the risk of reported adverse events.
Several methodological limitations undermined the strength of evidence in our study. The heterogeneity of the studies was the most significant limitation. The studies in our meta-analysis included patients with different spinal pathologies and operations. Although all the stud- ies included patients with simple disc ruptures, which were treated by discectomy or decompressive laminectomy, 3 studies also included more complex cases involving spinal stenosis and one of these (Jirarattanaphochai et al. 23 ) included patients undergoing spinal fusion. Patients with spinal stenosis or patients undergoing spinal fusion were poorly represented in the review, whereas patients with simple disc herniations were well represented. It is unlikely, however, that the more complex procedures confounded the results, as the randomized design of these studies ensured similar complexity of procedures in both the treatment and control groups. There was insufficient data to test these more complicated cases in a subgroup analysis, although this might be possible if the authors of the original studies provided data in more detail or provided data sets for meta-analysis of individual patient data.
Furthermore, the studies were heterogeneous with respect to the epidural agents used and routes of administration. Some studies used epidural methylprednisolone applied via a fat graft, whereas others used dexamethasone administered via epidural irrigation; some studies administered bupivacaine with the steroids, as cointervention analgesia, whereas others used steroids alone (Table  1) . We attempted to account for this heterogeneity by performing subgroup analyses. Subgroup analyses could not demonstrate a difference between steroids administered alone and steroids administered as part of a cointervention analgesia treatment with respect to the postoperative consumption of analgesic agents and LOS (Figs. 5 and 6). There were insufficient data to perform further subgroup analyses of other study variables, such as routes of administration or types of steroid. However, we speculate that different routes of administration and cointervention analgesia could account for different rates of efficacy. The variability of the study outcomes and the lack of consistently used validated score tools posed a challenge in the review. The studies used different tools to measure pain and QOL, and these were measured at different postoperative time points (Table 3) . Quality of life measurement tools included the SF-36, the Disability Rating Index, an 8-point outcome scale, and a 5-point functional grade scale created by study authors. These scales were too different to allow clinical significance to be derived from the corresponding meta-analyses. In addition, these outcome scales were not validated in the study population so their clinical relevance is limited. Despite these shortcomings, more comparable measurements were employed for pain, postoperative consumption of analgesic agents, and LOS, which made these parameters more amenable to the meta-analysis. The short follow-up times limited the assessment of epidural steroids' long-term safety and efficacy. Only 5 of the studies reported more than 3 months of follow-up. This limited the availability of data to analyze long-term outcomes. Also, the long-term safety of epidural steroids could not be established since the majority of studies reported adverse events with less than 3 months of followup and one of the papers did not report on complications at all. Selective outcome reporting and publication bias could not be excluded from the meta-analysis. Therefore, it is conceivable that authors of some studies withheld results to report only more positive results. Increased transparency in reporting, for instance by adherence to reporting guidelines 36 or by provision of additional data as online supplements, would increase confidence in the findings of meta-analysis and would increase the utility and applicability of trial evidence in neurosurgery. Future research should employ a randomized controlled trial with validated study outcomes to assess the long-term effects of epidural steroids on pain and QOL, and encourage fully transparent data reporting. This would enable the community of spine surgeons to establish the long-term safety and efficacy of perioperative epidural steroids.
Conclusions
In conclusion, there is evidence that epidural steroids decrease short-term pain in adults undergoing lumbar spine surgery for degenerative spinal disease. This evidence is supported by trials of moderate methodological quality subject to outcome reporting bias and lacking validated outcomes. More research is required before establishing perioperative epidural steroids as an effective and safe adjunct to surgery for long-term pain reduction.
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